ARCHIVES

Phase III BETH Study Combining Avastin And Herceptin Open For Enrollment

This article is from The Cancer Letter archive.

Vol. 31 No. 6 | June 27, 2008

Download PDF Visit The Full Archive

Related Articles

Fredrickson, Upton Kill Plan To Convert FCRC To NIH Satellite, Will Continue L-B Contract

February 9, 1979

Bethesda System Revised For Reporting Pap Test Results

April 26, 2002

Task Force Urges HHS to Form Committee To Implement Genetic Testing Regulations

November 7, 1997

$1 Million Gift to Duke Funds Urologic Research Center.

November 24, 2000

Also FDA clarifies data requirements for phase I IND applications.

April 29, 2005

Five Year Survival Up To 48 Percent; DeVita Has “No Doubt” It Is Really Over 50 Percent Now

December 2, 1983